Synthesis of a 2-aryl-3-aroyl indole salt (OXi8007) resembling combretastatin A-4 with application as a vascular disrupting agent
- PMID: 24016002
- PMCID: PMC3985392
- DOI: 10.1021/np400374w
Synthesis of a 2-aryl-3-aroyl indole salt (OXi8007) resembling combretastatin A-4 with application as a vascular disrupting agent
Abstract
The natural products colchicine and combretastatin A-4 are potent inhibitors of tubulin assembly, and they have inspired the design and synthesis of a large number of small-molecule, potential anticancer agents. The indole-based molecular scaffold is prominent among these SAR modifications, leading to a rapidly increasing number of agents. The water-soluble phosphate prodrug 33 (OXi8007) of 2-aryl-3-aroylindole-based phenol 8 (OXi8006) was prepared by chemical synthesis and found to be strongly cytotoxic against selected human cancer cell lines (GI₅₀ = 36 nM against DU-145 cells, for example). The free phenol, 8 (OXi8006), was a strong inhibitor (IC₅₀ = 1.1 μM) of tubulin assembly. The corresponding phosphate prodrug 33 (OXi8007) also demonstrated pronounced interference with tumor vasculature in a preliminary in vivo study utilizing a SCID mouse model bearing an orthotopic PC-3 (prostate) tumor as imaged by color Doppler ultrasound. The combination of these results provides evidence that the indole-based phosphate prodrug 33 (OXi8007) functions as a vascular disrupting agent that may prove useful for the treatment of cancer.
Figures





Similar articles
-
Design, Synthesis and Biological Evaluation of 2-Phenyl Indole Analogues of OXi8006 as Colchicine Site Inhibitors of Tubulin Polymerization and Vascular Disrupting Agents.Bioorg Med Chem. 2025 Feb 1;118:117981. doi: 10.1016/j.bmc.2024.117981. Epub 2024 Nov 7. Bioorg Med Chem. 2025. PMID: 39667146
-
Synthesis and biological evaluation of structurally diverse 6-aryl-3-aroyl-indole analogues as inhibitors of tubulin polymerization.Eur J Med Chem. 2024 Jan 5;263:115794. doi: 10.1016/j.ejmech.2023.115794. Epub 2023 Sep 6. Eur J Med Chem. 2024. PMID: 37984295 Free PMC article.
-
Synthesis and biological evaluation of indole-based, anti-cancer agents inspired by the vascular disrupting agent 2-(3'-hydroxy-4'-methoxyphenyl)-3-(3″,4″,5″-trimethoxybenzoyl)-6-methoxyindole (OXi8006).Bioorg Med Chem. 2013 Nov 1;21(21):6831-43. doi: 10.1016/j.bmc.2013.07.028. Epub 2013 Jul 23. Bioorg Med Chem. 2013. PMID: 23993969 Free PMC article.
-
Indole, a core nucleus for potent inhibitors of tubulin polymerization.Med Res Rev. 2007 Mar;27(2):209-38. doi: 10.1002/med.20080. Med Res Rev. 2007. PMID: 16788980 Review.
-
Naphthalene combretastatin analogues: synthesis, cytotoxicity and antitubulin activity.J Enzyme Inhib Med Chem. 2004 Dec;19(6):521-40. doi: 10.1080/14756360412331280473. J Enzyme Inhib Med Chem. 2004. PMID: 15662956 Review.
Cited by
-
Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors.Molecules. 2021 Apr 27;26(9):2551. doi: 10.3390/molecules26092551. Molecules. 2021. PMID: 33925707 Free PMC article. Review.
-
Dynamic bioluminescence and fluorescence imaging of the effects of the antivascular agent Combretastatin-A4P (CA4P) on brain tumor xenografts.Cancer Lett. 2015 Jan 28;356(2 Pt B):462-9. doi: 10.1016/j.canlet.2014.09.038. Epub 2014 Oct 8. Cancer Lett. 2015. PMID: 25305449 Free PMC article.
-
Design, Synthesis and Biological Evaluation of Prodrugs of 666-15 as Inhibitors of CREB-Mediated Gene Transcription.ACS Med Chem Lett. 2022 Feb 17;13(3):388-395. doi: 10.1021/acsmedchemlett.1c00499. eCollection 2022 Mar 10. ACS Med Chem Lett. 2022. PMID: 35300089 Free PMC article.
-
Structural interrogation of benzosuberene-based inhibitors of tubulin polymerization.Bioorg Med Chem. 2015 Dec 15;23(24):7497-520. doi: 10.1016/j.bmc.2015.10.012. Bioorg Med Chem. 2015. PMID: 26775540 Free PMC article.
-
Structure Guided Design, Synthesis, and Biological Evaluation of Oxetane-Containing Indole Analogues.Bioorg Med Chem. 2023 Sep 7;92:117400. doi: 10.1016/j.bmc.2023.117400. Epub 2023 Jun 29. Bioorg Med Chem. 2023. PMID: 37556912 Free PMC article.
References
-
- Pinney KG, Pettit GR, Trawick ML, Jelinek C, Chaplin DJ. In: Antitumor Agents from Natural Products. 2nd ed. Cragg GM, Kingston DGI, Newman DJ, editors. Boca Raton, FL: CRC Press, Taylor and Francis Group; 2011. pp. 27–64.
-
- Hamel E. In: Microtubule Targets in Cancer Therapy. Fojo AT, editor. Totowa, NJ: Humana Press; 2008. pp. 1–20.
-
- Pettit GR, Cragg GM, Herald DL, Schmidt JM, Lohavanijaya P. Can. J. Chem. 1982;60:1374–1376.
-
- Pettit GR, Cragg GM, Singh SB. J. Nat. Prod. 1987;50:386–391. - PubMed
-
- Lin CM, Ho HH, Pettit GR, Hamel E. Biochemistry. 1989;28:6984–6991. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous